This website uses cookies and, in some cases, third-party cookies, to improve user experience. By clicking the button or continuing to use the website you agree to the use of cookies. To find out more, including how to change your settings, see our Cookie Policy.

Teva Pharmaceutical 3.15% 2026-10 USD

New bond issue: Teva Pharmaceutical (NYSE:TEVA) issued new debt notes (US88167AAE10, 88167AAE1) for 3.5B USD as of July 18, 2016.

Teva Pharmaceutical Finance NV operates in the Netherlands as a finance subsidiary of Teva Pharmaceutical Industries Limited, an Israeli multinational pharmaceutical company.

IssuerTeva Pharmaceutical Finance
Stock (Group)NYSE:TEVA
Bond TypeCorporate
CategorySenior, Callable, SEC Registered
Maturity DateOctober 1, 2026
Residual Duration5 years, 8 months, 12 days
CurrencyUSD (United States Dollar)
Coupon TypeFixed Rate
Coupon (Yearly)3.150%
Coupon FrequencySemiannual
Minimum Lot2,000 USD
Additional Lots1,000 USD
Issue DateJuly 21, 2016
Issued Amount3,500,000,000 USD
Issue Price99.730%
Maturity Price100.000%
Home ExchangeTRACE
Other ExchangesFrankfurt, Berlin, Stuttgart, EuroTLX
IsinUS88167AAE10
Cusip88167AAE1
Issue DocumentationIssue Prospectus
IndustryPharmaceuticals
SectorHealth Care
CountryNetherlands
RegionEurope developed


Bonds, Corporate, Health Care, Pharmaceuticals, Europe developed, Netherlands, USD, Fixed Rate, Income


Next Michelin ZC% 2023-11 USD

investopoli.com